Clinical Trials Browser

Brain Neoplasms

NCT02530658 2026-04-29

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Recruiting

2,500 enrolled

CNS

Central Nervous System Neoplasms, Genetic Predisposition to Disease

NCT06147414 2026-04-23

DANNIgene

Recruiting

550 enrolled

CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

Clinical Trials

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

DANNIgene

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

BRICCS

PROGLIO

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

BZKF-AYA

HEPHESTOS

GLIBAMIR

GliomiR

Bioenergetic Profiling and Cognition in GBM Patients

Immunophenotyping From Blood of Patients With Malignant Gliomas

GLIOMANOID

Gliomstudien

Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1

Gene Expression, Immunological Status and Metabolome in Glioma Patients